Suchergebnisse - "Larbouret, C."

PubPharm (17)

1

FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer

enthalten in: British journal of cancer | 2016

von Marzi, L. | Combes, E. | Vié, N. | +14

2

FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer

enthalten in: The British journal of cancer | 2016

von Marzi, L. | Combes, E. | Vié, N. | +14

3

Therapeutic activity of anti-AXL antibody against triple-negative breast cancer Patient Derived Xenografts and metastasis

enthalten in: Clinical cancer research | 2016

von Leconet, W. | Chentouf, M. | Du Manoir, S. | +12

4

Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy

enthalten in: Oncogene | 2014

von Leconet, W. | Larbouret, C. | Chardès, T. | +11

5

Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts

enthalten in: Annals of oncology | 2010

von Larbouret, C. | Robert, B. | Bascoul-Mollevi, C. | +7

6

Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2010

von Larbouret, C. | Robert, B. | Bascoul-Mollevi, C. | +7

7

Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts

enthalten in: Annals of oncology | 2009

von Larbouret, C. | Robert, B. | Bascoul-Mollevi, C. | +7

8

513 POSTER Anti-tumor effect of an anti-human Müllerian Inhibiting Substance type II receptor antibody in a nude mouse model for granulosa cell tumors: a new targeted therapy for ovarian cancer

enthalten in: European journal of cancer / EJC Supplements | 2008

von Kersual, N. | Garambois, V. | Salhi, I. | +6

9

541 POSTER Gemcitabine versus combined antibodies against EGF receptors in pancreatic cancer: preclinical findings for clinical development

enthalten in: European journal of cancer / EJC Supplements | 2008

von Larbouret, C. | Robert, B. | Mollevi, C. | +6

10

Concomitant use of radiotherapy and gemcitabine : preclinical findings and clinical practice

enthalten in: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique | 2004

von Azria, D. | Coelho, M. | Larbouret, C. | +6